Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ellaOne after 3 missed combined oral contraceptive pills
2017-002283-41Phase 4Completed
- Sponsor
- HRA Pharma
- Start
- Jul 2017
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of ulipristal in unintended pregnancy (2 arms), sponsored by HRA Pharma. Primary endpoint: Ovarian Activity Score. Started Jul 2017; status: completed.
02
Drugs
ulipristal
03
Conditions
unintended pregnancy
Beyond the preview
Go deeper on 2017-002283-41.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-002283-41.